Drawing for SAH SWISS ALP HEALTH

USPTO serial 79135874

SAH SWISS ALP HEALTH

Reviewed by CopyMark Law Group

Reg. 4586497Status 706Registered
Filing date
Status date
Registration date
Aug 19, 2014
Examiner
MACIOL II, EUGENE VALENTINE-JO
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with SAH SWISS ALP HEALTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

James R Menker

James R Menker Holley & Menker, PAPO Box 331937Atlantic Beach, FL 32233United States

Goods and services

ClassDescriptionStatusFirst use
005[ Pharmaceutical and veterinary preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders, stress and anxiety, namely, herbal pharmaceutical preparations; pharmaceutical and veterinary preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardio-vascular system; pharmaceutical and veterinary preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical and veterinary preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the immune system; pharmaceutical and veterinary preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculo-skeletal system, namely, bone and connective tissue diseases and bone and cartilage degenerative conditions; Chondroitin preparations for human and veterinary use; pharmaceutical and veterinary preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, systemic and topical pain relief medication and anti-inflammatories; pharmaceutical preparations and substances, namely, medicated skin care preparations for use in dermatology, namely, dermatitis and skin pigmentation diseases; pharmaceutical preparations and substances for use in ophthalmology, namely, ophthalmic preparations and ophthalmologic preparations; pharmaceutical preparations and substances for the prevention, treatment and alleviation of menopause, circulatory, neurologic, digestive, auto-immune, pulmonary, musculoskeletal, gastrointestinal, skeletal, viral, urinary, renal, infectious, or metabolic diseases, illnesses, disorders or conditions; sanitary preparations for medical use; ] dietetic food and substances for medical or veterinary use, namely, dietary and nutritional supplements in liquid, powder or solid forms, amino acids for nutritional purposes, powdered nutritional supplement concentrate, vitamin preparations, vitamin and mineral preparations for medical use, herbal supplements, medicinal herb extracts, protein supplements, nutritional supplements in the nature of carbohydrates in liquid, powder or solid forms, dietary fiber to aid digestion [, medicated creams and lotions for dermatological use; food for babies ] ; food supplements for humans and animals; [ medical plasters; medical dressings; herbicides; ] all the aforesaid goods of Swiss originACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 15, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 27, 2026INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Sep 30, 2025INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jan 30, 2025NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Jan 30, 202571AGREGISTERED-SEC.71 ACCEPTED—
Jan 28, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 25, 2024ES71TEAS SECTION 71 RECEIVED—
Aug 19, 2023REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Jul 14, 2023RNWLINTERNATIONAL REGISTRATION RENEWED—
Jun 25, 2021NA15SEC. 15 ACKNOWLEDGEMENT - E-MAILED—
Jun 25, 202115AKREGISTERED - SEC. 15 ACKNOWLEDGED—
Jun 25, 2021APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 20, 2021INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
May 6, 2021INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
May 6, 2021INPCINVALIDATION PROCESSED—
May 1, 2021INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jan 1, 2021E15RTEAS SECTION 15 RECEIVED—
Sep 1, 2020NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Sep 1, 202071AGREGISTERED-SEC.71 ACCEPTED—
Aug 31, 2020APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 12, 2020ES71TEAS SECTION 71 RECEIVED—
Mar 1, 2018CHLDCHANGE OF OWNER RECEIVED FROM IB—
Jan 23, 2015FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 10, 2014FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 10, 2014FIMPFINAL DISPOSITION PROCESSED—
Nov 19, 2014FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 19, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 3, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 30, 2014GPNXNOTIFICATION PROCESSED BY IB—
May 22, 2014NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 14, 2014OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 14, 2014OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
May 14, 2014NPUBNOTICE OF PUBLICATION—
Apr 25, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 23, 2014ALIEASSIGNED TO LIE—
Apr 1, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 13, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 13, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 13, 2014ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Mar 11, 2014CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 10, 2014CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 14, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 13, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 13, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 16, 2013RFNTREFUSAL PROCESSED BY IB—
Oct 28, 2013RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 25, 2013RFRRREFUSAL PROCESSED BY MPU—
Oct 24, 2013RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 23, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 16, 2013DOCKASSIGNED TO EXAMINER—
Sep 27, 2013MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 23, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 20, 2013LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Sep 19, 2013REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance